Alzheimer’s Disease Neuroimaging Initiative 2 (ADNI-2)

Long Study Name: Alzheimer’s Disease Neuroimaging Initiative 2

Study Type: Memory

Study Purpose

The ADNI 2 studywill look at the usefulness of imaging studies and biomarker tests, together with measurements of memory, thinking and daily functioning, in the future conduct of studies that will focus on the identification and treatment of Alzheimer’s disease at an early stage.  This study aims to produce data to be stored for these kinds of future research studies.  

 Study Design

  • MRIs at baseline visit, month 3, 6, 12 and 24
  • Positron Emission Tomography (PET) scans at baseline visit, month 24 and 48
  • Blood draw at screening, baseline visit, month 6, 12, 24, 36 and 48
  • Spinal fluid samples  at baseline visit, month 24 and 48

Study Qualifications

  •  Age: 55-90
  • Mild/moderate memory and thinking problems, a diagnosis of early Alzheimer’s disease or no memory complaints * 
    • *To screen for the no memory complaints group participant must be over 70 years old*
  • A study partner who can come to clinic visits with you
  • Willing to undergo all study procedures including imaging and lumbar puncture

Study Duration

54 months

Study Benefits

  • Memory and medical screenings at no cost to you

Study Contact

 If you are interested in participating in ADNI 2, call 713-8477 or email  lgordine@wakehealth.edu

Last Updated: 01-13-2014
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.